Literature DB >> 3300359

Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells.

N Suttorp, W Seeger, S Zinsky, S Bhakdi.   

Abstract

The effects of the terminal complement sequence on prostacyclin (PGI2) generation in antibody-sensitized pulmonary arterial endothelial cells were examined. Whereas C5b-7 complement complexes induced no PGI2 formation, addition of purified complement component C8 resulted in a time- and dose-dependent burst of PGI2 release in the absence of overt cell damage. Formation of the complete terminal complement complex C5b-9 enhanced PGI2 release but was accompanied by cytolysis. Extracellular Ca2+ was required for C5b-8-dependent PGI2 formation. Three different blockers of physiological calcium channels failed to suppress the observed stimulatory effect. In contrast, W7 [N-(6-amino-hexyl)-5-chloro-1-naphthalene sulfonamide] and trifluoperazine, inhibitors of calmodulin activity, all reduced the C5b-8-dependent PGI2 generation. None of the inhibitors used impaired Ca2+ flux into the cells. One minute after addition of C8 to endothelial cells carrying C5b-7 complexes, a six- to seven-fold enhanced passive influx of 45Ca2+ into the cells was noted. An enhanced passive influx was also observed for 51Cr O4(2-), [3H] aminobutyric acid, and [3H]sucrose, but not for [3H]inulin and [3H]dextran. These data together suggest that complement C5b-8 complexes may serve as Ca2+ bypass gates in endothelial cells, the ensuing influx of Ca2+ leading to subsequent activation of the arachidonic acid pathway.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300359     DOI: 10.1152/ajpcell.1987.253.1.C13

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Adenosine diphosphate-ribosylation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro.

Authors:  N Suttorp; M Polley; J Seybold; H Schnittler; W Seeger; F Grimminger; K Aktories
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 2.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

3.  Complement induces a transient increase in membrane permeability in unlysed erythrocytes.

Authors:  J A Halperin; A Nicholson-Weller; C Brugnara; D C Tosteson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  Effects of Escherichia coli hemolysin on endothelial cell function.

Authors:  N Suttorp; B Flöer; H Schnittler; W Seeger; S Bhakdi
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Glutathione redox cycle is an important defense system of endothelial cells against chronic hyperoxia.

Authors:  N Suttorp; S Kästle; H Neuhof
Journal:  Lung       Date:  1991       Impact factor: 2.584

6.  Hyperpermeability of pulmonary endothelial monolayer: protective role of phosphodiesterase isoenzymes 3 and 4.

Authors:  N Suttorp; P Ehreiser; S Hippenstiel; M Fuhrmann; M Krüll; H Tenor; C Schudt
Journal:  Lung       Date:  1996       Impact factor: 2.584

7.  Effect of staphylococcal alpha-toxin on intracellular Ca2+ in polymorphonuclear leukocytes.

Authors:  N Suttorp; E Habben
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells.

Authors:  K K Hamilton; P J Sims
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

9.  The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.

Authors:  K S Kilgore; C M Flory; B F Miller; V M Evans; J S Warren
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

10.  Differential regulation of endothelial cell activation by complement and interleukin 1alpha.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2006-03-02       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.